Global Pompe Disease Drugs Sales Market Report Forecast 2017 to 2022

December 2017 | 118 pages | ID: G04446D1950EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
company 9

Product Segment Analysis:
Liver Drugs
Heart Drugs
Muscle Drugs

Application Segment Analysis:
Hospital
Clinic
Other

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 POMPE DISEASE DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Pompe Disease Drugs
1.2 Classification of Pompe Disease Drugs
  1.2.1 Liver Drugs
  1.2.2 Heart Drugs
  1.2.3 Muscle Drugs
1.3 Application of Pompe Disease Drugs
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 Pompe Disease Drugs Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Pompe Disease Drugs (2012-2022)
  1.5.1 Global Pompe Disease Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Pompe Disease Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON POMPE DISEASE DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 POMPE DISEASE DRUGS MANUFACTURING COST ANALYSIS

3.1 Pompe Disease Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Pompe Disease Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Pompe Disease Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL POMPE DISEASE DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Pompe Disease Drugs Market Competition by Manufacturers
  5.1.1 Global Pompe Disease Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Pompe Disease Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Pompe Disease Drugs (Volume and Value) by Type
  5.5.1 Global Pompe Disease Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Pompe Disease Drugs (Volume and Value) by Regions
  5.3.1 Global Pompe Disease Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Pompe Disease Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Pompe Disease Drugs (Volume) by Application

6 UNITED STATES POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Pompe Disease Drugs Sales and Value (2012-2017)
  6.1.1 United States Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Pompe Disease Drugs Sales Price Trend (2012-2017)
6.2 United States Pompe Disease Drugs Sales and Market Share by Manufacturers
6.3 United States Pompe Disease Drugs Sales and Market Share by Type
6.4 United States Pompe Disease Drugs Sales and Market Share by Application

7 CHINA POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Pompe Disease Drugs Sales and Value (2012-2017)
  7.1.1 China Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Pompe Disease Drugs Sales Price Trend (2012-2017)
7.2 China Pompe Disease Drugs Sales and Market Share by Manufacturers
7.3 China Pompe Disease Drugs Sales and Market Share by Type
7.4 China Pompe Disease Drugs Sales and Market Share by Application

8 EUROPE POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Pompe Disease Drugs Sales and Value (2012-2017)
  8.1.1 Europe Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Pompe Disease Drugs Sales Price Trend (2012-2017)
8.2 Europe Pompe Disease Drugs Sales and Market Share by Manufacturers
8.3 Europe Pompe Disease Drugs Sales and Market Share by Type
8.4 Europe Pompe Disease Drugs Sales and Market Share by Application

9 JAPAN POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Pompe Disease Drugs Sales and Value (2012-2017)
  9.1.1 Japan Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Pompe Disease Drugs Sales Price Trend (2012-2017)
9.2 Japan Pompe Disease Drugs Sales and Market Share by Manufacturers
9.3 Japan Pompe Disease Drugs Sales and Market Share by Type
9.4 Japan Pompe Disease Drugs Sales and Market Share by Application

10 GLOBAL POMPE DISEASE DRUGS MANUFACTURERS ANALYSIS

10.1 Genzyme（A Sanofi Company)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 BioMarin
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Amicus
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Audentes
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 EpiVax
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Oxyrane
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Sangamo
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Valerion Therapeutics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL POMPE DISEASE DRUGS MARKET FORECAST (2017-2022)

13.1 Global Pompe Disease Drugs Sales, Revenue Forecast (2017-2022)
13.2 Global Pompe Disease Drugs Sales Forecast by Regions (2017-2022)
13.3 Global Pompe Disease Drugs Sales Forecast by Type (2017-2022)
13.4 Global Pompe Disease Drugs Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Pompe Disease Drugs
Table Classification of Pompe Disease Drugs
Figure Global Sales Market Share of Pompe Disease Drugs by Type in 2016
Table Applications of Pompe Disease Drugs
Figure Global Sales Market Share of Pompe Disease Drugs by Application in 2016
Figure United States Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure China Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Global Pompe Disease Drugs Sales and Growth Rate (2012-2022)
Figure Global Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Table Global Pompe Disease Drugs Sales of Key Manufacturers (2012-2017)
Table Global Pompe Disease Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Pompe Disease Drugs Sales Share by Manufacturers
Figure 2016 Pompe Disease Drugs Sales Share by Manufacturers
Table Global Pompe Disease Drugs Revenue by Manufacturers (2012-2017)
Table Global Pompe Disease Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Pompe Disease Drugs Revenue Share by Manufacturers
Table 2016 Global Pompe Disease Drugs Revenue Share by Manufacturers
Table Global Pompe Disease Drugs Sales and Market Share by Type (2012-2017)
Table Global Pompe Disease Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Type (2012-2017)
Figure Global Pompe Disease Drugs Sales Growth Rate by Type (2012-2017)
Table Global Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
Table Global Pompe Disease Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Type (2012-2017)
Figure Global Pompe Disease Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Pompe Disease Drugs Sales and Market Share by Regions (2012-2017)
Table Global Pompe Disease Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Regions (2012-2017)
Figure Global Pompe Disease Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Pompe Disease Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Pompe Disease Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Regions (2012-2017)
Figure Global Pompe Disease Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Pompe Disease Drugs Sales and Market Share by Application (2012-2017)
Table Global Pompe Disease Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Application (2012-2017)
Figure Global Pompe Disease Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure United States Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure United States Pompe Disease Drugs Sales Price Trend (2012-2017)
Table United States Pompe Disease Drugs Sales by Manufacturers (2012-2017)
Table United States Pompe Disease Drugs Market Share by Manufacturers (2012-2017)
Table United States Pompe Disease Drugs Sales by Type (2012-2017)
Table United States Pompe Disease Drugs Market Share by Type (2012-2017)
Table United States Pompe Disease Drugs Sales by Application (2012-2017)
Table United States Pompe Disease Drugs Market Share by Application (2012-2017)
Figure China Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure China Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure China Pompe Disease Drugs Sales Price Trend (2012-2017)
Table China Pompe Disease Drugs Sales by Manufacturers (2012-2017)
Table China Pompe Disease Drugs Market Share by Manufacturers (2012-2017)
Table China Pompe Disease Drugs Sales by Type (2012-2017)
Table China Pompe Disease Drugs Market Share by Type (2012-2017)
Table China Pompe Disease Drugs Sales by Application (2012-2017)
Table China Pompe Disease Drugs Market Share by Application (2012-2017)
Figure Europe Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Europe Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Europe Pompe Disease Drugs Sales by Manufacturers (2012-2017)
Table Europe Pompe Disease Drugs Market Share by Manufacturers (2012-2017)
Table Europe Pompe Disease Drugs Sales by Type (2012-2017)
Table Europe Pompe Disease Drugs Market Share by Type (2012-2017)
Table Europe Pompe Disease Drugs Sales by Application (2012-2017)
Table Europe Pompe Disease Drugs Market Share by Application (2012-2017)
Figure Japan Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Japan Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Japan Pompe Disease Drugs Sales by Manufacturers (2012-2017)
Table Japan Pompe Disease Drugs Market Share by Manufacturers (2012-2017)
Table Japan Pompe Disease Drugs Sales by Type (2012-2017)
Table Japan Pompe Disease Drugs Market Share by Type (2012-2017)
Table Japan Pompe Disease Drugs Sales by Application (2012-2017)
Table Japan Pompe Disease Drugs Market Share by Application (2012-2017)
Table Genzyme（A Sanofi Company) Basic Information List
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genzyme（A Sanofi Company) Pompe Disease Drugs Global Market Share (2012-2017)
Table BioMarin Basic Information List
Table BioMarin Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BioMarin Pompe Disease Drugs Global Market Share (2012-2017)
Table Amicus Basic Information List
Table Amicus Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amicus Pompe Disease Drugs Global Market Share (2012-2017)
Table Audentes Basic Information List
Table Audentes Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Audentes Pompe Disease Drugs Global Market Share (2012-2017)
Table EpiVax Basic Information List
Table EpiVax Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure EpiVax Pompe Disease Drugs Global Market Share (2012-2017)
Table Oxyrane Basic Information List
Table Oxyrane Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Oxyrane Pompe Disease Drugs Global Market Share (2012-2017)
Table Sangamo Basic Information List
Table Sangamo Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sangamo Pompe Disease Drugs Global Market Share (2012-2017)
Table Valerion Therapeutics Basic Information List
Table Valerion Therapeutics Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Valerion Therapeutics Pompe Disease Drugs Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Pompe Disease Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pompe Disease Drugs
Figure Manufacturing Process Analysis of Pompe Disease Drugs
Figure Pompe Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
Table Major Buyers of Pompe Disease Drugs
Table Distributors/Traders List
Figure Global Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Pompe Disease Drugs Sales Forecast by Regions (2017-2022)
Table Global Pompe Disease Drugs Sales Forecast by Type (2017-2022)
Table Global Pompe Disease Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics